ENTITY
Jenscare Scientific

Jenscare Scientific (9877 HK)

40
Analysis
Health Care • China
Jenscare Scientific develops, produces, sells, and services minimally invasive interventional therapies for structural heart diseases. Key products include LuX-Valve and LuX-Valve Plus for tricuspid valve replacement, Ken-Valve for aortic valve replacement, and JensClip for mitral valve repair. The company is headquartered in Ningbo, Zhejiang, PRC, and was founded in 2011.
more
bullish•Swire Pacific
•25 Feb 2023 16:00

HSCI Index Rebalance: 35 Adds, 28 Deletes & Changes to Southbound Stock Connect

There are 35 adds & 28 deletes for the HSCI in March leading to 29 adds & 20 deletes for Stock Connect. 19 index constituents could be dropped from...

Logo
963 Views
Share
•12 Feb 2023 09:20

China Healthcare Weekly (Feb.10) - Assisted Reproduction into NRDL, Cell Therapy, Medicilon, IRay,

Medical insurance coverage of assisted reproduction has limited positive effects;Mr Market may not hold much hope for cell therapy after valuation...

Logo
791 Views
Share
•04 Jan 2023 06:29

HSCI Index Rebalance Preview and Stock Connect: A Lot of Change

We forecast 44 adds/19 deletes for the HSCI in March leading to 37 adds/deletes for Southbound Stock Connect. There could be more Connect changes...

Logo
1.1k Views
Share
•07 Oct 2022 11:01

Jenscare (健世科技) IPO Trading: Weak Demand and Share Concentration

We provide an update for the Jenscare IPO before trading debut. We note the weak demand and share concentration. Shares are unlikely to crash on...

Logo
542 Views
Share
bullish•Tencent
•02 Oct 2022 07:57

ECM Weekly (2nd Oct 2022) - Onewo, Leapmotor, CALB, Socionext, WCP, Oyo, Ixigo, Tencent, Taiwan Cemt

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
667 Views
Share
x